- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: triptorelin, 6-month formulation, advanced prostate cancer
Total 95424 results
-
BioProtectCompletedProstate CancerUnited States
-
Myriad Genetic Laboratories, Inc.TerminatedProstate CancerUnited States
-
Novartis PharmaceuticalsCompletedSoft Tissue Sarcoma | Small Cell Lung Cancer | Gastric Adenocarcinoma | Diffuse Large B Cell Lymphoma | Esophageal Adenocarcinoma | Ovarian Adenocarcinoma | Castration Resistant Prostate Adenocarcinoma | Advanced Well-differentiated Neuroendocrine TumorsUnited States
-
NRG OncologyNational Cancer Institute (NCI)CompletedRecurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | Prostate Adenocarcinoma | Stage IV Breast Cancer | Recurrent Breast Carcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | Male Breast CarcinomaUnited States, Canada, Switzerland
-
SanofiTerminatedProstate Cancer | Non-small Cell Lung CancerTaiwan, United States, France, Italy, United Kingdom
-
BioProtectCompletedProstate CancerUnited States, Israel, United Kingdom, Netherlands, Poland, Portugal
-
Incyte CorporationTerminatedSolid TumorsUnited States, Belgium, France
-
Rahul AggarwalNational Cancer Institute (NCI); National Institutes of Health (NIH)TerminatedProstate CancerUnited States
-
Dana-Farber Cancer InstituteMedivation, Inc.CompletedProstate Cancer | Prostate Adenocarcinoma | High Risk Prostate CancerUnited States
-
BHR Pharma, LLCQ2 Solutions; H2O Clinical LLCTerminatedCancer of the ProstateUnited States
-
Lawson Health Research InstituteOntario Institute for Cancer ResearchCompleted
-
Eisai Inc.PharmaBio Development Inc.TerminatedBladder CancerUnited Kingdom, Netherlands, Spain, Germany, United States, Ukraine
-
Janssen Research & Development, LLCCompletedCastration-Resistant Prostatic NeoplasmsCanada, Belgium, United States, Spain, Netherlands, Italy, Russian Federation
-
Allarity TherapeuticsCompletedPhase 1: Advanced or Refractory Solid Tumours | Phase 2 Part: Metastatic Breast Cancer, Prostate Cancer and Skin CancerDenmark
-
Brown UniversityAstraZeneca; The Miriam Hospital; Rhode Island HospitalTerminatedProstate Cancer | Adenocarcinoma of the ProstateUnited States
-
Asan Medical CenterDong-A PharmaceuticalCompletedProstatic NeoplasmsKorea, Republic of
-
Myovant Sciences GmbHCompletedA Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)Prostate CancerUnited States, Germany, Spain, New Zealand, Brazil, Belgium, Australia, Austria, Canada, China, Denmark, Finland, France, Italy, Japan, Korea, Republic of, Netherlands, Poland, Slovakia, Sweden, Taiwan, United Kingdom
-
Dana-Farber Cancer InstituteSanofiCompletedProstate CancerUnited States
-
BURHAN DOSTOndokuz Mayıs UniversityCompletedPain, Postoperative | Anesthesia, Local | Prostate CancerTurkey
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedSolid TumorsUnited States, Korea, Republic of, Taiwan, France, United Kingdom, Belgium, Czechia, Germany, Poland
-
Ferring PharmaceuticalsCompleted
-
Medical University of South CarolinaTerminated
-
Veru Inc.CompletedProstate Cancer MetastaticUnited States
-
National Institute of Allergy and Infectious Diseases...WithdrawnHIV Infections | Cytomegalovirus Retinitis
-
PfizerEMD Serono; Astellas Pharma Inc; Nektar TherapeuticsTerminatedSquamous Cell Carcinoma of the Head and Neck (SCCHN) | Metastatic Castration Resistant Prostate Cancer (mCRPC)Spain, United States, Poland, Belgium
-
CelgeneCompletedNeoplasm Metastasis | Prostate Cancer | Chronic Lymphocytic Leukemia | Glioblastoma Multiforme | Squamous Cell Carcinoma of Head and Neck | Ewing's OsteosarcomaUnited States, Spain, France, Germany
-
Corvus Pharmaceuticals, Inc.Genentech, Inc.CompletedRenal Cell Cancer | Metastatic Castration Resistant Prostate CancerUnited States, Canada, Australia
-
Jerome Canady, M.D.Active, not recruitingStage IV Lung Cancer | Stage IV Bladder Cancer | Stage IV Pancreatic Cancer | Recurrent Malignant Solid Neoplasm | Stage IV Breast Cancer | Stage IV Renal Cell Cancer | Stage IV Prostate Cancer | Stage IV Colon Cancer | Stage IV Rectal Cancer | Stage IV Gastric Cancer | Stage IV Non-small Cell Lung Cancer | Stage... and other conditionsUnited States
-
George Washington UniversityTerminatedProstate AdenocarcinomaUnited States
-
University of Lausanne HospitalsAdvanced Accelerator ApplicationsCompleted
-
Latin American Cooperative Oncology GroupJanssen PharmaceuticalsCompleted
-
ABX advanced biochemical compounds GmbHCompletedProstate Cancer | Prostate Cancer RecurrentFrance
-
University of DundeeNHS Tayside; Chief Scientist Office of the Scottish Government; Prostate Cancer... and other collaboratorsCompletedProstate CancerUnited Kingdom
-
University of California, San FranciscoCompletedMetastatic Prostate CancerUnited States
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health...Active, not recruiting
-
Impact Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Advanced Solid TumoursChina
-
Impact Therapeutics, Inc.CompletedBreast Cancer | Ovarian Cancer | Prostate Cancer | Primary Peritoneal Cancer | Advanced Solid TumoursAustralia
-
Boston Scientific CorporationAugmenix, Inc.Completed
-
Merck Sharp & Dohme LLCTerminatedNon-small Cell Lung Cancer (NSCLC) | Triple Negative Breast Cancer (TNBC) | NUT Midline Carcinoma (NMC) | Castration-resistant Prostate Cancer (CRPC)
-
Oncoethix GmbHCompletedTriple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma | Castrate-resistant Prostate Cancer | CRPC | NUT Midline Carcinoma | Non-small Cell Lung Cancer With Rearranged ALK Gene/Fusion Protein or KRAS Mutation
-
Novita Pharmaceuticals, Inc.Translational Drug DevelopmentCompletedBreast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer | Pancreas Cancer | Liver Cancer | Ovary Cancer | Esophagus Cancer | Advanced or Metastatic Treatment-refractory Solid Tumor MalignanciesUnited States
-
University of OxfordVaccitech (UK) LimitedUnknownCastration-resistant Prostate Cancer | Intermediate Risk Prostate CancerUnited Kingdom
-
PharmaMarTerminatedProstate CancerUnited States
-
Amsterdam UMC, location VUmcActive, not recruitingProstate Cancer Metastatic to BoneNetherlands
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Effector TherapeuticsTerminated
-
University of VirginiaJohns Hopkins University; Virginia Commonwealth UniversityUnknownDecision Support TechniquesUnited States
-
Advanced Accelerator ApplicationsTerminatedBreast Cancer | Small Cell Lung Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung CancerAustria, France
-
AbbVieTerminatedGlioblastoma | Medullary Thyroid Cancer | Malignant Melanoma | Other Solid Tumors | Large-Cell Neuroendocrine Carcinoma | Neuroendocrine Prostate Cancer | High Grade Gastroenteropancreatic Neuroendocrine Carcinoma | Other Neuroendocrine CarcinomaUnited States
-
Massachusetts General HospitalCompletedLung Cancer | Solid Tumor (Not Breast or Prostate Cancers)United States